Academic papers, patent filings, and R&D activity signals.
Breakthrough research and patent activity can signal future competitive advantages months before they're priced in. Fin45 monitors arXiv preprints, USPTO patent filings, and clinical trial databases for signals relevant to publicly traded companies.
When a company's researchers publish breakthrough results (especially in AI, biotech, or materials science), it often precedes product announcements or partnerships. Fin45 links authors to their employers.
Clusters of patent filings in new technology areas, defensive patent acquisitions, and patents that reference competitor technology can signal strategic direction.
Research signals typically lead by 3–12 months. They're used to build long-term conviction rather than short-term trading triggers.
Fin45 publishes every trade 10 days after close. Subscribe to The Gap for daily signal summaries.
Subscribe Free →